Abstract
The plasma membrane (NCX) and mitochondrial (NCLX) Na+/Ca2+ exchangers are structurally related proteins, although they operate under strictly different ionic conditions and membrane potentials. In contrast with NCX, NCLX can transport either Li+ or Na+ in exchange for Ca2+. Whereas the crystal structure of the archaeal NCX (NCX_Mj) describes the binding sites for alternative binding of 3Na+ or 1Ca2+, these features remain elusive for NCLX due to the lack of structural information. To elucidate the ion-binding features of mitochondrial NCLX, we analyzed here the Li+-transporting NCLX_Mj mutant, produced by replacing the ion-coordinating residues in the archaeal NCX (NCX_Mj) to match the ion-coordinating residues of human NCLX. The NCLX_Mj-mediated Na+/Ca2+ or Li+/Ca2+ exchange rates are insensitive to varying voltage, consistent with an electroneutral ion exchange. Molecular dynamics (MD) simulations revealed that NCLX_Mj contains two novel Li+ binding sites with four ion-coordinating residues, derived from the three Na+ binding sites of NCX_Mj. The ion-coordination modes, observed in the MD simulations, were further supported by two-dimensional infrared (2D IR) spectroscopy and by testing the mutational effects on the ion fluxes. Collectively, our results revealed a structural basis for Li+ binding and electroneutral transport (2Na+/Li+:1Ca2+) by NCLX_Mj, meaning that the NCLX-mediated electroneutral transport may predefine mitochondrial Ca2+ and Na+ signaling to modulate cellular functions.
Original language | English |
---|---|
Article number | 102651 |
Journal | Cell Calcium |
Volume | 107 |
DOIs | |
State | Published - Nov 2022 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022
Funding
We wish to thank Prof. Israel Sekler for helpful and meaningful discussions. We also thank the Blavatnik Center for Drug Discovery (Tel-Aviv University) for providing the technical and professional support needed to perform the MD simulation. This work was supported by the Israel Science Foundation (#1351/18 to DK), the National Institutes of Health (R35GM133359 to CRB), the Welch Foundation (F-1891 to CRB), the Israel Cancer Research Fund (19202 to MG), and Kahn Foundation's Orion project, Tel Aviv Medical Center (to MG). We wish to thank Prof. Israel Sekler for helpful and meaningful discussions. We also thank the Blavatnik Center for Drug Discovery (Tel-Aviv University) for providing the technical and professional support needed to perform the MD simulation. This work was supported by the Israel Science Foundation ( #1351/18 to DK ), the National Institutes of Health ( R35GM133359 to CRB ), the Welch Foundation ( F-1891 to CRB ), the Israel Cancer Research Fund ( 19202 to MG ), and Kahn Foundation's Orion project, Tel Aviv Medical Center (to MG).
Funders | Funder number |
---|---|
Kahn Foundation | |
Tel Aviv Medical Center | |
National Institutes of Health | |
National Institute of General Medical Sciences | R35GM133359 |
Welch Foundation | F-1891 |
Israel Cancer Research Fund | 19202 |
Israel Science Foundation | 1351/18 |
Tel Aviv University |
Keywords
- 2D IR
- Ion selectivity
- Ion-binding sites
- NCLX
- NCX
- Sodium-calcium exchanger